Related Articles
Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas
Clinical implications of hypoxia‑inducible factor‑1α and caveolin‑1 overexpression in isocitrate dehydrogenase‑wild type glioblastoma multiforme
Identification of key candidate genes and pathways in glioblastoma by integrated bioinformatical analysis
Altered capicua transcriptional repressor gene expression exhibits distinct prognostic value for isocitrate dehydrogenase-mutant oligodendroglial tumors
Identification of differential splicing genes in gliomas using exon expression profiling